NCT05980546View on ClinicalTrials.gov

Genicular and Anterior Femoral Cutaneous Nerve Blocks for Total Knee Arthroplasty

PHASE4CompletedINTERVENTIONAL
Enrollment

244

Participants

Timeline

Start Date

June 7, 2023

Primary Completion Date

September 5, 2025

Study Completion Date

September 11, 2025

Conditions
Total Knee ReplacementGenicular Nerve BlockOpioid Use
Interventions
DRUG

Bupivacaine Injection

The genicular nerve block and anterior femoral cutaneous nerve blocks consists of bupivacaine with preservative-free dexamethasone injections.

DRUG

Dexamethasone injection

The genicular nerve block and anterior femoral cutaneous nerve blocks consists of bupivacaine with preservative-free dexamethasone injections.

DRUG

Fentanyl

This is a drug that is given as part of the analgesia and sedation regime. This drug is not the study intervention.

DRUG

Mepivacaine

This is a drug that is given as part of the analgesia and sedation regime. This drug is not the study intervention.

Trial Locations (1)

10021

Hospital for Special Surgery, New York

All Listed Sponsors
lead

Hospital for Special Surgery, New York

OTHER

NCT05980546 - Genicular and Anterior Femoral Cutaneous Nerve Blocks for Total Knee Arthroplasty | Biotech Hunter | Biotech Hunter